US-based CardioKinetix has announced the successful treatment of first two Chinese heart failure patients with its Parachute ventricular partitioning device, a minimally invasive treatment for patients with heart failure caused by damage to ...
Tags: CardioKinetix, Partitioning Device
CardioKinetix has announced the first successful procedure in four cardiac patients with its new catheter-based Parachute ventricular partitioning device in Kuala Lumpur, Malaysia. The new Parachute device is a new minimally invasive ...
CardioKinetix has completed enrolling the first patient in PARACHUTE IV trial of its Parachute ventricular partitioning device for treating heart failure patients. The minimally invasive device is deployed into the left ventricle to ...
CardioKinetix has reported positive three-year clinical data of its minimally invasive Parachute ventricular partitioning device, following Percutaneous Ventricular Restoration therapy in heart failure patients. The Parachute device, ...
Tags: CardioKinetix, clinical data, Parachute, ventricular partitioning device
CardioKinetix has started enrolling patients for its PARACHUTE III, a post-market safety surveillance trial, in Germany. The dual-arm, multi-center, open-label trial, which will enroll up to 100 ischemic heart failure patients, is ...
CardioKinetix has obtained CE mark approval for its full size matrix of its percutaneous ventricular restoration device to treat patients with ischemic heart failure. The Parachute ventricular partitioning device uses a small catheter ...
Tags: CE Mark, heart failure, medical device